Results 61 to 70 of about 44,151 (306)

Development and validation of spectrophotometric method for quantitative determination of carvedilol in tablets [PDF]

open access: yes, 2021
INTRODUCTION: Carvedilol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.AIM: The aim of this article is to develop a spectrophotometric method
Maletska, Olena   +2 more
core   +2 more sources

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results

open access: yesHeart International, 2014
Background Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk, correlating with risk of heart disease, silent myocardial ischemia or sudden cardiac death.
Heather L. Bloom   +2 more
doaj   +1 more source

Effects of MDMA on body temperature in humans [PDF]

open access: yes, 2014
Hyperthermia is a severe complication associated with the recreational use of 3,4-methylenedioxymethamphetamine(MDMA, Ecstasy). In this review, the clinical laboratory studies that tested the effects of MDMA on body temperature are summarized.
Liechti, Matthias E.
core   +1 more source

Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety

open access: yesJGH Open, 2022
Background and Aim Beta blockers combined with endoscopic variceal band ligation (EVL) is the most effective means for the prevention of variceal rebleeding.
Chantelli Iamblaudiot Razafindrazoto   +8 more
doaj   +1 more source

Carvedilol in hypertension treatment

open access: yesVascular Health and Risk Management, 2008
Although beta-blockers have been previously shown to effectively reduce blood pressure (BP) and have been used for hypertension treatment for over 40 years, their effect on cardiovascular morbidity and mortality in hypertensive patients remains controversial and its use in uncomplicated hypertension is currently under debate. However, data on the above
Panagiotis Stafylas, Pantelis Sarafidis
openaire   +4 more sources

Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study

open access: yesAlimentary Pharmacology and Therapeutics, 2020
Primary prophylaxis of variceal haemorrhage with non‐selective beta blockers (NSBB) or variceal band ligation (VBL) is now standard of care in patients with cirrhosis with portal hypertension.
Hannah R McDowell   +5 more
semanticscholar   +1 more source

Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT [PDF]

open access: yes, 2016
Aims: During the post-discharge phase following a heart failure hospitalization (HFH), patients are at high risk of early readmission despite standard of care therapy.
Abrahamsson   +34 more
core   +4 more sources

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate an influence of carvedilol on risk of hypoglycemia in patients with diabetes type 2 (D2) and chronic heart failure (CHF) treated with angiotensin converting enzyme (ACE) inhibitors.Material and methods. 13 patients (10 men, 3 women; aged
A. A. Aleksandrov   +6 more
doaj   +1 more source

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? [PDF]

open access: yes, 2003
ObjectivesThis study examined the relative merits of digoxin, carvedilol, and their combination for the management of patients with atrial fibrillation (AF) and heart failure (HF).BackgroundIn patients with AF and HF, both digoxin and beta-blockers ...
Cleland, John G.F   +5 more
core   +1 more source

The β-arrestin-biased β-adrenergic receptor blocker carvedilol enhances skeletal muscle contractility

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2020
Significance We recently demonstrated that the effects of the β2AR agonist clenbuterol to enhance skeletal muscle strength and hypertrophy are mediated via β-arrestin1-dependent signaling.
Jihee Kim   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy